Nouvelles Eulerpool Cytosorbents

Eulerpool-AFX Cytosorbents

Cytosorbents Actualités des actions

Cytosorbents est surveillé par de nombreux journalistes et investisseurs du monde entier. Nous regroupons ici les dernières actualités Cytosorbents.

• 4 novembre ·

  Yahoo
  CytoSorbents Submits Health Canada Medical Device License Application for DrugSorb-ATR Following MDSAP Certification
• 22 octobre ·

  Yahoo
  FDA Accepts DrugSorb-ATR De Novo Application To Reduce the Severity of CABG-Related Bleeding Due to Ticagrelor and Initiates Substantive Review
• 22 octobre ·

  Benzinga
  Expert Outlook: CytoSorbents Through The Eyes Of 5 Analysts
• 22 octobre ·

  Seeking Alpha
  CytoSorbents rises as FDA accepts application for device to reduce bleeding risk in bypass surgery
• 22 octobre ·

  TipRanks
  CytoSorbents announces FDA has accepted De Novo medical device application
• 17 octobre ·

  Yahoo
  CytoSorbents to Report Third Quarter 2024 Operating and Financial Results
• 10 octobre ·

  Yahoo
  CytoSorbents Corp (CTSO) Q2 2024 Earnings Call Highlights: Revenue Growth and Strategic ...
• 1 octobre ·

  Yahoo
  CTSO: CytoSorbents Announces Submission of DrugSorb-ATR Application to the FDA
• 1 octobre ·

  Yahoo
  CytoSorbents Submits DrugSorb-ATR Marketing Application to U.S. FDA to Reduce the Severity of Bleeding in Heart Bypass Surgery Patients on the Blood Thinner Ticagrelor and Provides Business Update
• 1 octobre ·

  Seeking Alpha
  CytoSorbents spikes on FDA submission for DrugSorb-ATR